Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the tally of failed drugs in the innovative “Healey platform trial” to seven.

ActiGraph, which makes digital tools used in clinical trials, acquired the life sciences business of Biofourmis, once ...

The revenue from operations jumped 43% YoY to ₹291 crore in Q2 FY25, compared to ₹203 crore in the same quarter of the previous year.

Jaswant Kaur finds permanent relief from heart condition through successful Radiofrequency Catheter Ablation at NIMS ...

Located near Chikkaballapur in Karnataka’s capital Bengaluru, this state of the art hospital provides free treatment for any ...

HBM Healthcare Investments AG / Key word (s): Quarter Results HBM Healthcare Investments reports a compelling 15 percent increase in NAV in the 2024 calendar year 03-Jan-2025 / 17:48 CET/CEST Release ...

The IPO is entirely an OFS, the company will not receive any funds from the issue and the proceeds will go to the selling ...

Anthem Biosciences, a CRDMO specializing in drug discovery, development and manufacturing, has filed draft papers with Sebi ...

Indian contract drugmaker Anthem Biosciences filed for a 33.95-billion-rupee ($397 million) initial public offering, ...

Anthem, whose services include early-stage drug discovery and drug efficacy testing, said private equity firm True North and drugmaker DavosPharma are among investors who will sell shares in the IPO.

HYDERABAD: Till December 30, the Anti-Corruption Bureau (ACB) registered 213 cases, including 126 trap cases, 11 related to ...